The [China Eclinical Solution Market] is powered by a diverse range of end-users, with pharmaceutical companies currently representing the largest segment. Their dominance is due to their robust R&D investments and the need for efficient clinical trial processes to manage large, complex studies . However, the market is witnessing a significant shift, with biotechnology...